Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02398669 · ClinicalTrials.gov registry record · Phase 1
A Single Dose Pharmacokinetic Study of Lorcaserin Hydrochloride in Obese Pediatric Subjects 6 to 11 Years of Age
A Phase 1 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT02398669 is a Phase 1 study that has completed, run by Eisai. The registered enrollment target is 10 participants.
The verdict
NCT02398669, a Phase 1 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
Study will evaluate the pharmacokinetics (PK), safety and tolerability of a single 10 mg dose of lorcaserin hydrochloride in obese pediatric subjects 6 to 11 years of age.
Interventions
- DRUG Lorcaserin hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-03 |
| Est. Completion | 2015-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02398669
The ClinicalTrials.gov registry entry for NCT02398669 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lorcaserin hydrochloride is the first listed.
NCT02398669 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02398669 about?
NCT02398669 is a clinical study titled "A Single Dose Pharmacokinetic Study of Lorcaserin Hydrochloride in Obese Pediatric Subjects 6 to 11 Years of Age". Study will evaluate the pharmacokinetics (PK), safety and tolerability of a single 10 mg dose of lorcaserin hydrochloride in obese pediatric subjects 6 to 11 years of age.
What is the current status of trial NCT02398669?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2015-03. Estimated completion is 2015-05.
What interventions are being tested in trial NCT02398669?
The interventions under investigation include: Lorcaserin hydrochloride (DRUG).
Who is sponsoring clinical trial NCT02398669?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.